S Proteasome Market
Global S Proteasome Market Size, Share & Trends Analysis Report By Type (Bortezomib, Carfilzomib, and Ixazomib) and By Application (Hospital, Clinic, and Other) Forecast 2022-2028
The global S Proteasome market is anticipated to grow at a significant CAGR of 6.5% during the forecast period. Proteasome inhibitors are now being used to treat a wide range of blood cancers, most notably myeloma. Cancer is becoming more prevalent. Despite the presence of various types of drugs to treat solid tumors, there is still a significant demand for novel cancer therapeutics. So, increasing funding and R&D to develop more novel treatments will create market opportunities. Additionally, proteasome inhibitors that are currently available have a high efficacy in treating blood cancer indications, and vendors also are conducting research on the effects of these therapeutics on solid tumors.
Moreover, a large unmet need and expanded application of proteasome inhibitors are two factors expected to drive market growth in the coming years. Proteasome inhibitors prevent or slow the degradation of proapoptotic factors, allowing programmed cell death to occur, which eventually cures the disease. Vendors have been developing them in the late stages of clinical trials for multiple myeloma and drugs for pancreatic cancer in order to gain a foothold on the market. These factors will contribute to the market's expansion.
Impact of COVID-19 Pandemic on Global S Proteasome Market
The COVID-19 pandemic had impacted the global S proteasome market report significantly owning to the lockdown in most of the nations to control the spread of the virus. The market for S proteasome was also declined due to the disruptions in the supply chain of essential medical supplies and medical devices in the year 2020. Despite a significant economic downturn, the companies in the S proteasome market had adopted new strategies to recover.
Segmental Outlook
The global S proteasome market is segmented based on type and application. Based on the type, the market is segmented into bortezomib, carfilzomib, and ixazomib. Based on application the market is sub-segmented into hospital, clinic, and other. Among these, the application segment is anticipated to propel the growth of the market over the forecast period, owing to the rising inclination of cancer.
Global S Proteasome Market Share by Type, 2020 (%)
The Bortezomib Segment is Anticipated to Hold a Prominent Share in the Global S Proteasome Market
Based on the type, the bortezomib segment holds a significant share in the global S proteasome market. The bortezomib is considered one of the approved proteasome inhibitor drugs for the purpose of providing effective treatment associated with cancer and acts by reversibly inhibiting the proteasomal activity in order to do addition to multiple oncogenic pathways in tumor cells. Additionally, multiple myeloma cell lines are considered more sensitive for providing treatment with bortezomib for healthy individuals.
Regional Outlooks
The global S proteasome market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America).
Global S Proteasome Market Growth, by Region 2022-2028
The Asia-Pacific Region is estimated to Hold the Major Share in the Global S Proteasome Market
The Asia-Pacific region is expected to witness significant growth opportunities for the market. Improving health care infrastructure, and the increasing investment made by government and companies are acting as the prime factors impacting the market in the region. Additionally, technology advancement in different countries of Asia-Pacific including India, China, and Japan along with growing patient population is expected to drive the growth of the market in the region.
Market Players Outlook
The major companies serving the global S Proteasome market include AstraZeneca, Amgen Inc, Cayman Chemical, Gyma Laboratories of Americ, and Hangzhou Longshine Bio-Tech Co. Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2021, Amgen Inc., had set forth that US Food and Drug Administration (FDA) had given the approval in order to enlarge the KYPROLIS (carfilzomib) US prescribing information to include its use in combination with DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) and dexamethasone in order to provide effective treatment of adult patients with relapsed or refractory multiple myeloma.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global S Proteasome market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global S Proteasome Market
- Recovery Scenario of Global S Proteasome Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Astrazeneca
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Amgen Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Cayman Chemical
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Gyma Lab. Of Americ
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Hangzhou Longshine Bio-Tech Co. Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global S Proteasome Market by Type
4.1.1. Bortezomib
4.1.2. Carfilzomib
4.1.3. Ixazomib
4.2. Global S Proteasome Market by Application
4.2.1. Hospital
4.2.2. Clinic
4.2.3. Other
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Johnson & Johnson Services, Inc.
6.2. Natco Pharma
6.3. Shanghai Chiral Chemicals
6.4. Takeda Pharmaceutical Company Ltd.
6.5. Tecoland Corp.
6.6. TG Therapeutics Inc.
6.7. Vijayasri organics Ltd.
1. GLOBAL S PROTEASOME MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL BORTEZOMIB IN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL CARFILZOMIB IN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL IXAZOMIB IN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL S PROTEASOME MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
6. GLOBAL HOSPITAL IN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL CLINIC IN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OTHER IN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL S PROTEASOME MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
12. NORTH AMERICAN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
13. EUROPEAN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. EUROPEAN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15. EUROPEAN S PROTEASOME MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC S PROTEASOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC S PROTEASOME MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC S PROTEASOME MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. REST OF THE WORLD S PROTEASOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. REST OF THE WORLD S PROTEASOME MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
21. REST OF THE WORLD S PROTEASOME MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL S PROTEASOME MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL S PROTEASOME MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL S PROTEASOME MARKET, 2022-2028 (%)
4. GLOBAL S PROTEASOME MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL BORTEZOMIB INS PROTEASOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL CARFILZOMIB IN S PROTEASOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL IXAZOMIBIN IN S PROTEASOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL S PROTEASOME MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
9. GLOBAL HOSPITAL IN S PROTEASOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL CLINIC IN S PROTEASOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL OTHER IN S PROTEASOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL S PROTEASOME MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. US S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
14. CANADA S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
15. UK S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
16. FRANCE S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
17. GERMANY S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
18. ITALY S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
19. SPAIN S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
20. REST OF EUROPE S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
21. INDIA S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
22. CHINA S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
23. JAPAN S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
24. SOUTH KOREA S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF ASIA-PACIFIC S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF THE WORLD S PROTEASOME MARKET SIZE, 2021-2028 ($ MILLION)
